Rapid corticosteroid tapering in acute eosinophilic pneumonia
Not Applicable
Completed
- Conditions
- Diseases of th respiratory system
- Registration Number
- KCT0001352
- Lead Sponsor
- Armed Forces Capital Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 59
Inclusion Criteria
Patients who were diagnosed with acute eosinophilic pneumonia
1) an acute onset of febrile respiratory manifestations < 1 month in duration regardless of hypoxemia status, 2) bilateral diffuse infiltrates evident on chest radiography, 3) > 25% eosinophils in bronchoalveolar lavage or eosinophilic pneumonia evident on lung biopsy, and, 4) absence of any known cause of pulmonary eosinophilia, including drug abuse, toxin exposure, or infection.
Exclusion Criteria
Patients who were not diagnosed with acute eosinophilic pneumonia
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment failure: clinical deterioration after stopping corticosteroid treatment
- Secondary Outcome Measures
Name Time Method Time to overall clinical stabilization from diagnosis;Time to complete resolution of all symptoms and clinical instabilities from diagnosis;Adverse events during corticosteroid treatment;Durations of additional medications to relieve adverse effects